FMI Technologies, Inc.

Focused... for better Outcomes

FMI Technologies has innovations of molecular medical imaging combined with molecular probes for the heart and the brain.

FMI Technologies, Inc. (FMI) has developed a portable and dedicated ultra high resolution multimodality diagnostic imaging technology for early detection and monitoring of neurodegenerative disorders, cardiovascular disease, breast cancer, and prostate cancer. 

FMI’s ScintiStar^TM Cardiac PET/CT/SPECT offers 7x-10x improvement quantifying Myocardial Perfusion for Cardiovascular Disease detection and planning of therapy. The system enables earlier detection and better quantification of Cardiovascular disease with novel PET perfusion isotope biomarker for reduction of invasive cardiac catheterizations.  

Also, FMI’s ScintiStar^TM Neuro PET/CT/SPECT systems offer a superior and more cost-effective imaging solution with 3x-5x times improved resolution that enables advanced therapy and possible cures for Alzheimer’s disease (“Alzheimer’s” or “AD”), Vascular Dementia, Parkinson’s disease and other psychiatric diseases like Schizophrenia and Depression.

In addition, its unique Fused^[i] Multimodality Imaging will offer the data critical to earlier physician diagnosis of stroke, head and neck cancers, coronary artery disease, breast cancer, and prostate cancer than are possible with current technology.

FMI’s mantra is “Drugs need Imaging and Imaging needs Drugs” for early asymptomatic diagnostics and personalized medicine. FMI provides “Point of Care Diagnostics” for cardiac and neurologic diseases. FMI has strategic corporate alliances with Lantheus Medical Imaging for the ScintiStar Cardiac. Lantheus and FMI are working together for 7x- 10x improvement in resolution with Lantheus’s F18 Myocardial Perfusion Imaging agent and the small footprint ScintiStar Cardiac system for cardiologists.

FMI Products

FMI ScintiStar^TM Cardiac LPX PET/CT

FMI ScintiStar^TM LPX CT

FMI ScintiStar^TM HPX PET/CT

FMI ScintiStar^TM HPX CT

FMI ScintiStar^TM Neuro LPX PET/CT

FMI ScintiStar^TM Mammo LPX PET/CT

 

[i]PET/CT/SPECT images are combined, or "fused", to provide information as to the sensitivity and specificity for the type of cancer present, three dimensional information as to the physical location of the cancer and reference information for doctors to plan